All posts tagged
The Most Important Battle in Gene Editing: CRISPR versus TALEN
Taking CAR-T Cells Beyond Cancer: A New Therapy for Autoimmune Disease
French Biotech Gets a CRISPR Patent for CAR-T Research
Scottish CAR-T Biotech Adds Another Stellar Partner to Its Roster
Can Lentiviral Vectors Give CAR-T a Run for Its Money?
Another Huge Acquisition Sees CAR-T Stocks Jump – Except for Celyad
A Cure for Cancer? How CAR-T Therapy is Revolutionizing Oncology
German Biotech Raises Record $270M Series A for Individualized Cancer Therapies
The Biggest Biotech News of 2017: What Happened This Year?
Interviews, Reviews and Tops: Our Best Biotech Articles from 2017
How to Deal with Regulations to Get Approval for CAR-T Cells
Smile! Here are the 12 Biggest Biotech Clinical Successes of 2017
Labiotech UG, All Rights Reserved -